Introducing the SomaScan® 11K Assay – capable of 11,000 total protein measurements
Find out more at the Festival of Genomics & Biodata in London
Join us at the Festival of Genomics & Biodata at ExCel, London – January 24-25, 2024
Join our sponsored session (details below), and stop by booth 71 to learn more about the most powerful proteomics solution today – covering half of the genetically encoded human proteome. Researchers can now decipher human biology by casting the widest net possible with the SomaScan 11K Assay.
at booth 71
Attend our sponsored presentation
Application of Proteomics Within a Large-Scale Prospective Cohort to Identify Novel Biomarkers for Chronic Diseases
Thursday 25 January | 12:00-12:30 p.m. | Location: Other Stage
Presenter: Professor Marc Gunter
Chair in Cancer Epidemiology and Prevention
Cancer Epidemiology and Prevention Research Unit
School of Public Health
Imperial College London
High dimensional proteomic profiling within large-scale prospective cohorts has the potential to uncover novel biomarkers of chronic diseases and diagnostic markers, as well as aid understanding of etiologic pathways. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), a longitudinal cohort of >500,000 Europeans, Dr. Gunter recently applied SomaScan® Assay technology to ~18,000 participants within a case-cohort setting with cancer, cardiovascular disease, diabetes and mortality endpoints. In this presentation, Dr. Gunter will provide an overview of the study design and some preliminary findings with a focus on cancer outcomes.